QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The impact of biomass burning on total suspended particulate matter in the southeastern Tibetan Plateau 期刊论文 ATMOSPHERIC ENVIRONMENT, 2018, 卷号: 193, 页码: 33-39 作者:  Zhang, NN (Zhang, Ning-Ning)[ 1 ];  Wang, QY (Wang, Qi-Yuan)[ 1 ];  Su, XL (Su, Xiao-Li)[ 1 ];  Zhang, T (Zhang, Ting)[ 1 ];  Tao, J (Tao, Jun)[ 2 ] 收藏  |  浏览/下载：90/0  |  提交时间：2018/11/21 Levoglucosan  Biomass burning  Tibetan plateau   The impact of biomass burning on total suspended particulate matter in the southeastern Tibetan Plateau 期刊论文 ATMOSPHERIC ENVIRONMENT, 2018, 卷号: 193, 页码: 33-39 作者:  Zhu, CS (Zhu, Chong-Shu)[ 1 ];  Zhang, NN (Zhang, Ning-Ning)[ 1 ];  Wang, QY (Wang, Qi-Yuan)[ 1 ];  Su, XL (Su, Xiao-Li)[ 1 ];  Zhang, T (Zhang, Ting)[ 1 ] 收藏  |  浏览/下载：71/0  |  提交时间：2018/11/21 Levoglucosan  Biomass Burning  Tibetan Plateau   Asymmetric Quinoxaline-Based Polymer for High Efficiency Non-Fullerene Solar Cells 期刊论文 2018, 卷号: 34, 期号: 11, 页码: 1272 作者:  Yuan Jun[1];  Liu Ye[1];  Zhu Can[1];  Shen Ping[2];  Wan Meixiu[3] 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/10 Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases 期刊论文 CIRCULATION, 2018, 卷号: 137, 期号: 13, 页码: 1374-+ 作者:  Zhang, Lei[1];  Wei, Ting-Ting[2];  Li, Yong[3];  Li, Jing[4];  Fan, Yong[5] 收藏  |  浏览/下载：16/0  |  提交时间：2019/12/24 biomarkers  cardiovascular diseases  coronary artery disease  metabolomics  myocardial ischemia  neuraminidase   YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction 期刊论文 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 卷号: 1864, 期号: 12, 页码: 3786-3798 作者:  Dai, Chun-Hua[1];  Shu, Yang[2];  Chen, Ping[3];  Wu, Jian-Nong[4];  Zhu, Li-Haun[5] 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/24 Non-small cell lung cancer  Epidermal growth factor receptor-tyrosine  kinase inhibitors (EGFR-TKIs)  Erlotinib  Resistance  YM155  Survivin